|
|
40
|
|
|
5041P
|
|
|
OXALIPLATIN 50MG SOLN FOR INJ (FSB/ATB)
|
|
|
OXALIPLATIN
|
|
|
OXALIPLATIN
|
|
|
50MG VIAL
|
|
|
BQ
|
|
|
38.06
|
|
|
38.06
|
|
|
50MG
|
|
|
SOLUTION FOR
|
|
|
0
|
|
|
VIAL
|
|
|
FSB
|
|
|
FLAGSHIP BIOTECH
|
|
|
ATB
|
|
|
ANSA TRADING BARBADOS LTD
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|